Study finds tuberculosis changes liver metabolism and could promote diabetes
Scientists have discovered that tuberculosis disrupts glucose metabolism in the body.
Noticias
New discovery could change autoimmune therapy landscape
Researchers have discovered a family of enzymes that work to reduce IgG-mediated pathologies in diseases like MG. The findings, involving mouse models, show that a specific enzyme (an endoglycosidase called CU43) was particularly effective in treating …
Stalking ribosomes: How cancer cells pull poker faces
The protein factories of our cells are much more diverse than we thought they were. Scientists have now shown that cancer cells can use these so-called ribosomes to boost their invisibility cloak, helping them hide from the immune system.
Researchers unveil inhibition mechanism of receptors on natural killer cells
A research team led by Prof. Zhou Rongbin from the University of Science and Technology of China (USTC) discovered the mechanism by which lysophosphatidylserine (LysoPS) inhibits the anti-tumor activity of natural killer (NK) cells through its receptor…
Understanding the maturation of white blood cells to find new therapies against lymphoblastic leukemia
More than 400 people, 80% of them being children under 14 years old, will be diagnosed with B-cell Acute Lymphoblastic Leukemia (B-ALL) next year in Spain, according to the latest projections from the Spanish network of cancer registries (REDECAN). Sur…
Monoclonal antibodies have the potential to treat severe asthma bouts, scientists find
Scientists from the University of Sharjah think monoclonal antibodies hold the potential to be a far better treatment for asthma exacerbations than conventional therapies like steroids.
How cancer cells may be using ribosomes to hide from the immune system
The protein factories of our cells are much more diverse than we thought they were. Scientists from the Netherlands Cancer Institute have now shown that cancer cells can use these ribosomes to boost their invisibility cloak, helping them hide from the …
Research highlights enzyme’s therapeutic potential in managing immune-related disorders
Myasthenia gravis (MG) is a chronic autoimmune disorder in which antibodies block communication between nerves and muscle, resulting in weakness of the skeletal muscles. It can cause double vision, difficulty swallowing, and, occasionally, serious brea…
Q&A: How research can make immunotherapy effective in an increasing number of breast cancers
Immunotherapy has become the most promising strategy for treating cancer, but its effectiveness is still very uneven. In the month of breast cancer, the most common tumor in women—almost 2.5 million cases are diagnosed worldwide each year—three researc…
A new era of treating neurological diseases at the blood-brain-immune interface
A group of scientists say it’s time to think differently about how to define and treat diseases such as Alzheimer’s and multiple sclerosis.